STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ALDX ALDEYRA THERAPEUTICS INCORPORATED StockScouter® Report
3
StockScouter® Score
ALDEYRA THERAPEUTICS INCORPORATED, a small cap company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
Concerns
- The multi-period measure of relative price change and consistency is well below average. Negative
- Moving average analysis for ALDX suggests weak price movement over the medium term. Negative
- One or more analysts has modestly decreased quarterly earnings estimates for ALDX. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, stocks will be , and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
B
D
N/A
F